CCM
IRWD icon

Coldstream Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Coldstream Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.2K Sell
10,269
-1,119
-10% -$4.31K ﹤0.01% 1214
2026
Q1 		$40K Sell
11,388
-912
-7% -$3.74K ﹤0.01% 1181
2025
Q4 		$41.5K Buy
12,300
+1,299
+12% +$3.37K ﹤0.01% 1154
2025
Q3 		$14.4K Buy
+11,001
New +$11.4K ﹤0.01% 1213

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Coldstream Capital Management's IRWD Position: Q2 2026 in Review

Coldstream Capital Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 9.8% in Q2 2026, selling an estimated $4.31K and leaving 10,269 shares worth $43.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1214.

Coldstream Capital Management first reported a position in IRWD in Q3 2025 and has held it in 4 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Coldstream Capital Management held 10,269 shares of Ironwood Pharmaceuticals worth $43.2K as of Q2 2026.
  • Coldstream Capital Management sold 1,119 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $4.31K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #1214 holding.
  • Coldstream Capital Management first reported a position in Ironwood Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.